Table 4.

Tumor/organ ratios for [¹⁷⁷Lu]PentixaTher, [¹⁷⁷Lu]DOTA-r-a-ABA-CPCR4 and [¹⁷⁷Lu]DOTA-r-a-ABA-iodoCPCR4 in Daudi xenograft bearing CB-17 SCID mice at 48h p.i. (groups of n=4-5 animals). Data are means ± SD.

	[177Lu]PentixaTher	[177Lu]DOTA-r-a-ABA-CPCR4	[177Lu]DOTA-r-a-ABA-iodoCPCR4
t/blood	201 ± 27	949 ± 146	320 ± 104
t/heart	31 ± 4	111 ± 20	42 ± 7
t/lung	16 ± 5	47 ± 22	14 ± 2
t/liver	0.4 ± 0.1	1.0 ± 0.2	0.6 ± 0.1
t/spleen	2.1 ± 0.5	8.3 ± 2.8	3.0 ± 0.7
t/stomach	27 ± 6	46 ± 32	58 ± 12
t/small intestine	29 ± 6	55 ± 36	50 ± 20
t/colon	13 ± 5	20 ± 10	19 ± 13
t/kidney	2.7 ± 0.4	2.9 ± 0.4	3.1 ± 0.9
t/muscle	85 ± 15	413 ± 100	226 ± 36